Clincosm LogoSign in Get a demo

Glioblastoma

Showing NaN - NaN of 55
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Glioma, Astrocytoma, Glioblastoma Trial in Durham (nivolumab, DC)

Completed
Has Results
  • Malignant Glioma
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Mar 11, 2020

Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma Trial in United States (Bevacizumab, Rindopepimut (CDX-110) with

Completed
  • Glioblastoma
  • +6 more
  • Birmingham, Alabama
  • +44 more
Feb 12, 2020

Anaplastic Astrocytoma, Brain Stem Glioma, Childhood Mixed Glioma Trial in United States (radiation, other, drug)

Completed
Has Results
  • Anaplastic Astrocytoma
  • +12 more
  • 3-Dimensional Conformal Radiation Therapy
  • +5 more
  • Los Angeles, California
  • +11 more
Jul 17, 2019

LITT Palliative Treatment for Patients With Malignant Gliomas

Withdrawn
  • Malignant Glioma of Brain
  • Glioblastoma
  • Palliative regimen consisting of LITT
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke
Feb 26, 2019

Anaplastic Astrocytoma, Anaplastic Ependymoma, Astrocytoma, Grade II Trial in United States (imetelstat sodium)

Terminated
Has Results
  • Anaplastic Astrocytoma
  • +8 more
  • imetelstat sodium
  • Los Angeles, California
  • +10 more
Jun 20, 2018

Glioblastoma Trial in Worldwide (Bevacizumab, Onartuzumab, Placebo)

Completed
  • Glioblastoma
  • Birmingham, Alabama
  • +61 more
Feb 2, 2018

Glioblastoma Trial in Durham (CMV-ALT + CMV-DCs, CMV-ALT + Saline)

Completed
  • Glioblastoma
  • CMV-ALT + CMV-DCs
  • CMV-ALT + Saline
  • Durham, North Carolina
    Duke University Medical Center
Jan 26, 2018

Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma Trial in Worldwide (Rindopepimut (CDX-110) with GM-CSF,

Completed
  • Glioblastoma
  • +4 more
  • Rindopepimut (CDX-110) with GM-CSF
  • +2 more
  • Birmingham, Alabama
  • +222 more
Jan 11, 2018

Teratoid Tumor, Atypical, Choroid Plexus Tumors, Anaplastic Astrocytoma Trial in United States (azurin-derived cell-penetrating

Completed
  • Teratoid Tumor, Atypical
  • +9 more
  • azurin-derived cell-penetrating peptide p28
  • Los Angeles, California
  • +10 more
Aug 3, 2017

Malignant Glioma, Glioblastoma, Gliosarcoma Trial in United States (AP23573)

Completed
  • Malignant Glioma
  • +2 more
  • Boston, Massachusetts
  • +3 more
Aug 18, 2015

Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma Trial in United States (XL184, temozolomide, Radiation Therapy)

Completed
  • Glioblastoma
  • +2 more
  • Los Angeles, California
  • +7 more
Sep 19, 2014

Glioblastoma Trial in Durham (Temodar and Irinotecan)

Completed
  • Glioblastoma
  • Temodar and Irinotecan
  • Durham, North Carolina
    Duke University Health System
Aug 14, 2014

Glioblastoma Trial in Durham (SU011248 & Irinotecan)

Completed
  • Glioblastoma
  • SU011248 & Irinotecan
  • Durham, North Carolina
    Duke University Health System
Jul 18, 2014

Glioblastoma, Gliosarcoma Trial in Durham (Temodar and O6-Benzylguanine)

Completed
  • Glioblastoma
  • Gliosarcoma
  • Temodar and O6-Benzylguanine
  • Durham, North Carolina
    Duke University Health System
Jul 15, 2014

Glioblastoma, Gliosarcoma Trial in Durham (Erlotinib and Dasatinib)

Completed
  • Glioblastoma
  • Gliosarcoma
  • Erlotinib and Dasatinib
  • Durham, North Carolina
    Duke University Health System
Jul 15, 2014

Glioblastoma, Gliosarcoma, Brain Tumor Trial in Durham (Avastin, Temozolomide, Radiation Therapy (XRT))

Completed
Has Results
  • Glioblastoma
  • +2 more
  • Durham, North Carolina
    Duke University Health System
Apr 22, 2014

Glioblastoma, Gliosarcoma Trial in Durham (Avastin, Bortezomib)

Completed
Has Results
  • Glioblastoma
  • Gliosarcoma
  • Durham, North Carolina
    Duke University Health System
Feb 7, 2014

Glioblastoma, Gliosarcoma, Anaplastic Astrocytoma Trial in Durham (Oral Topotecan and Temodar)

Completed
  • Glioblastoma
  • +2 more
  • Oral Topotecan and Temodar
  • Durham, North Carolina
    Duke University Health System
Oct 23, 2013

Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab and Etoposide)

Completed
Has Results
  • Glioblastoma
  • Gliosarcoma
  • Bevacizumab and Etoposide
  • Durham, North Carolina
    Duke University Health System
Jul 30, 2013

Glioblastoma, Gliosarcoma Trial in Durham (Erlotinib + sirolimus)

Completed
Has Results
  • Glioblastoma
  • Gliosarcoma
  • Erlotinib + sirolimus
  • Durham, North Carolina
    Duke University Health System
Aug 2, 2013

Glioblastoma, Gliosarcoma Trial in Durham (Temo + Avastin, VP-16 + Avastin)

Completed
Has Results
  • Glioblastoma
  • Gliosarcoma
  • Temo + Avastin
  • VP-16 + Avastin
  • Durham, North Carolina
    Duke University Health System
Jul 10, 2013

Glioblastoma, Gliosarcoma Trial in Durham (Temodar, O6-BG, and Irinotecan)

Completed
  • Glioblastoma
  • Gliosarcoma
  • Temodar, O6-BG, and Irinotecan
  • Durham, North Carolina
    Duke University Health System
Jun 18, 2013

Glioblastoma, Gliosarcoma Trial in Durham (Avastin and Temozolomide)

Completed
Has Results
  • Glioblastoma
  • Gliosarcoma
  • Avastin and Temozolomide
  • Durham, North Carolina
    Duke University Health System
May 20, 2013

Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab and Erlotinib)

Completed
Has Results
  • Glioblastoma
  • Gliosarcoma
  • Bevacizumab and Erlotinib
  • Durham, North Carolina
    Duke University Health System
Mar 29, 2013

Glioblastoma, Gliosarcoma Trial in Durham (Imatinib Mesylate & Hydroxyurea)

Completed
Has Results
  • Glioblastoma
  • Gliosarcoma
  • Imatinib Mesylate & Hydroxyurea
  • Durham, North Carolina
    Duke University Health System
Mar 13, 2013